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 6 
Abstract (100–120 words)  7 
The development and integration of DNA-based methods in research and clinical microbiology 8 
laboratories have enabled standardised and comprehensive detection and differentiation of the 9 
microbes colonising our guts. For instance, the single-celled parasites Blastocystis and 10 
Dientamoeba appear to be much more common than previously thought, especially so in healthy 11 
individuals. While increasing evidence appears to suggest limited pathogenicity of these parasites, 12 
next-generation sequencing-based studies have helped us appreciate links between parasite 13 
colonisation and certain host phenotypical characteristics and gut microbial profiles. The 14 
fundamental question remains as to whether such parasites are merely indicators or active 15 
manipulators of gut microbiota structure and function. In this article, we collate existing evidence 16 
that these parasites are, as a minimum, indicators of intestinal microbiota structure. 17 
 18 
Towards mapping of the human gut eukaryome 19 
An increasing body of evidence suggests links between gut microbiota composition and various 20 
diseases [1-6]. Application of a holistic view of the structure and function of the gut microbiota 21 
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requires the inclusion of not only bacteria, but also parasites, fungi, archaea, viruses, and phages [7-22 
12]. To some extent corroborating the “Old Friends hypothesis” (see Glossary), Parfrey et al. 23 
recently produced data exemplifying the “defaunation” of the human gut [13]. Here, diversity 24 
patterns of intestinal eukaryotes were compared between individuals with a westernized lifestyle 25 
(from the cities of Colorado and Philadelphia in USA) and individuals with an agrarian lifestyle 26 
(from rural communities in Malawi). The authors observed that individuals with non-western diets 27 
and lifestyles resemble non-human mammals in terms of micro-eukaryotic diversity, while 28 
individuals with a western lifestyle have low levels of micro-eukaryotic diversity.  29 
The introduction of real-time PCR and other DNA-based technologies including next-generation 30 
sequencing in modern clinical microbiology laboratories and research laboratories for detection and 31 
differentiation of intestinal parasites has opened up new avenues for exploring how parasites impact 32 
our lives [14]. For instance, the high sensitivity of real-time PCR tests has helped us understand that 33 
some parasites are—on an overall basis—much more common than previously anticipated, with 34 
prevalence rates approaching 100% in some communities, even in developed countries. Examples 35 
include Blastocystis and Dientamoeba, which appear to be more or less obligate eukaryotic 36 
members of the gut microbiota in some populations [15-21], while less frequent in others, including 37 
individuals with functional and organic bowel diseases and metabolic disorders [13, 22-25]. For 38 
instance, we recently showed Dientamoeba to be a consistent finding in the stool from children in 39 
childcare in Denmark [20], and similarly that Blastocystis is a frequent finding in children in 40 
Nigeria, with prevalence increasing by age [18]. We have also shown that healthy individuals are 41 
more likely to host these parasites than patients with irritable bowel syndrome (IBS) [25]  and, 42 
especially, inflammatory bowel disease (IBD) [22]. Moreover, it appears that Blastocystis, 43 
Dientamoeba and Entamoeba are capable of long-term colonization of the human gut [15, 16, 20, 44 
26]. For these parasitic genera, tools to differentiate colonization from infection are not available 45 
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[27-29]. It is also not unlikely that different genotypes or strains display different levels of virulence 46 
[30-32]. More precise molecular diagnostics are therefore required to allow for better mapping of 47 
strains/genotypes. However, in order to be able to distinguish clinically relevant strains from mere 48 
colonizers, a better understanding of the microbial eukaryotic contribution to the human gut 49 
ecosystem is probably required. 50 
The above-mentioned types of advances have spurred an interest in mapping and exploring the gut 51 
eukaryome [7-10], as well as investigating the interplay between gut parasites and gut bacteria. 52 
Interestingly, parasitic genera such as Blastocystis, Dientamoeba and Entamoeba, which are all 53 
considered luminal (i.e. non-invasive) intestinal parasites (except for Entamoeba histolytica, 54 
colonization by which may be invasive), appear more commonly in healthy individuals than in 55 
patients with metabolic, organic and functional gastrointestinal disorders [21, 23, 25, 33-36], which 56 
has promoted the idea of some parasites being beneficial to the host rather than culprits of disease 57 
[37]. Since vast differences in colonization rate are seen across age groups [17], health status [25], 58 
and geographical regions [13], which might be the factors driving these differences? While 59 
exposure to faecally contaminated matter is most likely one of these factors, another crucial factor 60 
might be individual susceptibility to colonization. In this regard, susceptibility to parasite infection 61 
may be linked to specific ecological conditions in the gut, including those that have to do with gut 62 
microbiota. This line of thinking is supported by several animal experimental studies that have 63 
provided evidence of probiotics preventing or modulating parasite infection [38]. In fact, the gut 64 
microbiota may not only be driving the susceptibility to, but also the outcome of, parasite infection, 65 
as suggested by Berrilli et al. [39]. Moreover, differences in microbiota signatures, i.e., differences 66 
in microbiota taxa, be it on the species, genus, family or even phylum level, may reflect the severity 67 
of parasite infections.  68 
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With the current opportunities for exhaustive gut microbiota profiling using next-generation 69 
sequencing, an important step towards fine-tuning our clinical and public health understanding of 70 
colonization by intestinal parasites is to study these parasites in relation to their ecological niche, 71 
including relationships with gut microbiota. Such steps are already being taken [40]; however, it is 72 
also important to develop hypotheses that might explain these relationships. 73 
 74 
Evidence of links between common intestinal parasites and gut bacterial communities 75 
Over the past few years, specific gut microbiota patterns have been shown to be linked to 76 
colonization with common parasitic protists (Table 1). Especially, the relationship between 77 
Blastocystis and gut bacteria has been a popular research focus [15, 23, 35, 41-47]. In 2011, 78 
Arumugam et al. launched the concept of enterotypes of the human gut microbiome [48]. 79 
Analysing the gut microbiota of healthy and diseased individuals across nations, they observed a 80 
clustering of individuals into one of three microbiota patterns, the so-called “enterotypes”. Each of 81 
these three enterotypes were identifiable by the variation in the levels of one of three bacterial 82 
genera: Bacteroides, Prevotella, and Ruminococcus. In the study by Arumugam et al., only bacterial 83 
data were communicated; no breakdown of the eukaryotic components of the gut microbiota was 84 
provided. To mitigate this and taking a retrospective approach to studying the data produced by 85 
Arumugam and colleagues, Andersen et al. [35] not only identified the prevalence and subtype 86 
distribution of Blastocystis in various cohorts of healthy and diseased individuals, but also explored 87 
links between Blastocystis and gut bacteria. They found that Blastocystis carriage was significantly 88 
less common in individuals with a Bacteroides-driven enterotype than in those with a 89 
Ruminococcus- or Prevotella-driven enterotype. They also found that Blastocystis colonization was 90 
associated with higher bacterial richness (number of individual bacterial taxa) and lower body mass 91 
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index (BMI) (findings summarized in [28]). A somewhat similar approach was recently taken by 92 
Beghini et al. [23], who found a strong link between Blastocystis, the Archaean 93 
Methanobrevibacter smithii and several bacterial species across 12 metagenomic datasets. 94 
Moreover, similar to observations made by Andersen et al. (2015), an inverse relationship was 95 
identified between Blastocystis carriage and BMI, showing that Blastocystis colonization is 96 
inversely associated with increasing BMI. 97 
To validate the findings by Andersen et al. in 2015 [35], members of the same team took to 98 
analyzing another set of faecal samples using real-time PCR technology [43]. Again, Blastocystis 99 
was investigated in relation to major groups of bacteria using a modified GUt Low-Density Array 100 
(GULDA)-approach and Dientamoeba was included in the study as well as a “control parasite”. 101 
Both Dientamoeba and Blastocystis were studied in relation to the six bacterial taxa Bacteroides, 102 
Prevotella, the butyrate-producing clostridial clusters IV and XIVa, the mucin-degrading 103 
Akkermansia muciniphila, and the indigenous group of Bifidobacterium, and it was observed that 104 
carriers of Blastocystis alone or along with Dientamoeba fragilis typically had gut microbiota 105 
characterized by low relative abundances of Bacteroides and clostridial cluster XIVa and high 106 
levels of Prevotella. Hence, colonization with Blastocystis was again linked to a low relative 107 
abundance of Bacteroides. In fact, when comparing parasite-negative with parasite-positive 108 
samples, the relative abundance of Bacteroides in the parasite-negative samples was significantly 109 
higher compared with parasite-positive samples (P < 0.001) [43].  110 
Audebert and colleagues performed a cross-sectional study including 48 Blastocystis-positive and 111 
48 Blastocystis-negative patients and performed 16S rDNA sequencing to map Blastocystis-112 
associated gut microbiota, identifying higher bacterial diversity in the faecal microbiota of 113 
Blastocystis-colonized patients, a higher abundance of clostridia, and a lower abundance of 114 
Enterobacteriaceae [41]. Earlier on, however, Nourrisson and colleagues had suggested that 115 
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Blastocystis might be linked to microbiota imbalance, observing that, compared with controls, 116 
levels of “gut-protective” Faecalibacterium prausnitzii were decreased in Blastocystis-colonised 117 
males and that levels of Bifidobacterium sp. were decreased in males with irritable bowel syndrome 118 
(IBS) type C [44]. 119 
In a study comparing the microbiota in individuals with Giardia, Blastocystis, and Entamoeba, 120 
dysbiosis, as evidenced by a low F. prausnitzii-Escherichia coli ratio, was identified in individuals 121 
with Giardia, while those with Blastocystis and Entamoeba appeared to be characterized by 122 
eubiosis, characterized primarily by a high F. prausnitzii-E. coli ratio [47].  123 
Studying the gut microbiota of African rural populations, Morton and colleagues  showed that 124 
across populations, intestinal colonisation by the genus Entamoeba could be predicted with 79% 125 
accuracy based on the composition of an individual's gut microbiota [49]. They moreover observed 126 
that several of the taxa critical to distinguishing the absence or presence of Entamoeba are in fact 127 
signature taxa for autoimmune disorders such as Crohn’s Disease. While this appears to suggest that 128 
Entamoeba is a surrogate marker for gut microbial communities protecting against gut 129 
inflammatory diseases, it is not clear whether the parasite per se might also play a role in the 130 
protection against this and other autoimmune conditions, bringing into memory the idea of the Old 131 
Friends hypothesis. 132 
Microbial profiling studies have indicated that the gut microbiota of patients with IBD differ from 133 
that of healthy individuals [50]. In patients with IBD, a decrease in strict anaerobic bacteria and a 134 
shift towards facultative anaerobes such as members of the family Enterobacteriaceae have been 135 
suggested to reflect disruption of anaerobiosis, indicating a role for oxygen in intestinal dysbiosis 136 
[53, 54]. Although it was known that oxygen concentrations increase in a disturbed gut ecosystem, 137 
it was only recently that the molecular mechanism was elucidated [55]. In a healthy gut, bacteria 138 
7 
 
produce butyrate [56], which is the preferred metabolic substrate of colonocytes [57]. Butyrate is 139 
used by colonic epithelial cells in the beta-oxidation pathway and yields ATP. This pathway uses 140 
molecular oxygen and thereby reduces the oxygen concentration in the intestine. In addition, the 141 
produced butyrate is sensed via a human nuclear receptor and subsequently represses the inducible 142 
nitric oxide synthase [55], which leads to a reduction of nitrate [58]. This all leads to a reduction in 143 
the proliferation of facultative anaerobes [55]. Butyrate is actually required to activate oxidative 144 
metabolism [59]. A shift away, caused by antibiotics for example, from obligate anaerobic bacteria 145 
from the Firmicutes and Bacteroides phyla towards members of the Enterobacteriaceae disrupts the 146 
host’s butyrate-linked control mechanism [55] and represses oxidative metabolism [59], increasing 147 
luminal oxygen in the human gut. This might partly explain why parasites such as Blastocystis are 148 
rare in patients with intestinal dysbiosis-linked diseases: Blastocystis being a strict anaerobe [60], it 149 
is expected that its ability to establish or maintain itself in a micro-aerophilic environment is limited 150 
(Figure 1).  151 
Taking all these studies into account, it appears that colonization by some intestinal parasites can be 152 
predicted with quite a high degree of accuracy merely by studying the composition of gut bacteria 153 
[23, 49], and the negative association between Blastocystis colonization and levels of Bacteroides 154 
shown by independent research groups [23, 35, 43] adds further support to this hypothesis. A 155 
possible explanation for the negative correlation between Blastocystis and Bacteroides might be that 156 
the latter, unlike the Firmicutes, generally are not the main butyrate producers in the gut [56] and 157 
therefore contribute to a lesser extent to an environment where Blastocystis thrives.  158 
 159 
Associations between microbial signatures and parasite pathogenicity 160 
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A few examples of links between microbes and parasite pathogenicity have been published. One 161 
example is the study by Gilchrist and colleagues, who observed that high parasite burden coupled 162 
with increased levels of Prevotella copri was linked to symptomatic infection with Entamoeba 163 
histolytica in Bangladeshi children [61]. Recently, members of the same group noticed that 164 
dysbiosis induced by antibiotic treatment increased the severity of amebic colitis and delayed 165 
clearance of E. histolytica in an amoebic colitis mouse model [62]. Other examples of links between 166 
E. histolytica virulence and gut microbiota were recently reviewed by Burgess and Petri [63]. 167 
Similarly, Giardia intestinalis, the most common waterborne cause of diarrhea, was also found to 168 
be associated with a perturbed intestinal microbiota in a mouse model system. Giardia infection 169 
was linked to an increase of facultatively and strictly aerobic bacteria [64]. However, an increase of 170 
Enterobacteriaceae normally seen in dysbiosis [54] was not seen in infections with Giardia, and 171 
strict aerobes belonging to the beta-proteobacteria increased instead suggesting that parasite-linked 172 
dysbiosis can lead to different microbiota compostions. Another example demonstrating differences 173 
in gut microbial diversity is found in helminth infections [65, 66]. Individuals infected with 174 
helminths showed a greater microbial diversity compared to individuals who were not infected. As 175 
the populations studied were indigenous Malaysians, their gut flora was not immediately 176 
comparable to other intestinal microbial diversity studies that generally focus on individuals 177 
consuming Western diets [13, 66]. Interestingly, in an experimental system, introduction of a 178 
benign tapeworm into a rat model did not lead to an increase of bacterial alpha diversity [67]. On 179 
the other hand, the gut microbiota of mosquitos did contribute to killing of the host when infected 180 
with a pathogenic fungus [68], demonstrating that the presence of gut microbiota does not 181 
automatically protect its host from a disastrous outcome after an infectious challenge. 182 
In many other environments, microbial eukaryotes play an important ecological role as bacterial 183 
grazers [69-71]. Nutrient cycling and bacterial protein turnover are important ecological roles 184 
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played by microbial eukaryotes, observed in e.g. intestinal systems such as the rumen of large 185 
herbivores [72]. Intestinal pathogens such as Entamoeba are also known to feed on bacteria, and 186 
perhaps where evidence of a causative link between disease and the presence of a given parasite is 187 
weak, microbial eukaryotes found in the intestine might have roles in the local food web by 188 
providing or recycling nutrients. Especially in cases where long-term colonization has been 189 
observed [15, 16, 20, 26], it might be prudent to consider alternative roles for microbial eukaryotes 190 
in the human gut other than causing disease; eradication of organisms traditionally considered 191 
pathogens might not always be advisable, bringing into mind again the “Old Friends” hypothesis 192 
[73].   193 
 194 
How can these links be explored in further detail? 195 
There are several ways in which to explore the above-mentioned links further. Some could involve 196 
studies of the parasite itself (including studies of the ecological requirements of the parasites 197 
[nutrition, oxygen tension, etc.] through genomic, transcriptomic and metabolomic analyses). 198 
Others could involve exhaustive microbiota surveys and experimental studies. Conclusions based 199 
on cross-sectional data, which are the data mostly available at present, could be confirmed by using 200 
longitudinal data (cohort studies) on individuals losing or gaining parasites to look for simultaneous 201 
changes in gut microbiota structure or function, by 16S analysis and PICRUSt analysis, 202 
respectively, or by the analysis of metagenomics data. Moreover, in vitro and in vivo models could 203 
be developed for testing the susceptibility to infection in similar hosts with different gut microbiota 204 
established by selective use of, for instance, pre- and probiotics, antibiotics, and/or co-infections. In 205 
vitro studies could take advantage of the fact that Blastocystis is one of the few parasites that are 206 
easily grown in the lab and could therefore make use of cultures where culture-negative stool is 207 
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grown in culture medium (e.g., Jones’ medium [74]) and later spiked with Blastocystis, keeping 208 
some cultures unspiked as controls. Longitudinal sampling before and after the spiking event could 209 
be used for studies of the relative stability of the faecal microbiota during Blastocystis colonization, 210 
and to explore changes in microbiota due to Blastocystis colonisation. 211 
One of the major limitations to developing integrative studies of the entire gut microbiota and the 212 
effect it exerts on human health and disease is the lack of genomic data on gut parasites. No matter 213 
whether metagenomics or amplicon-based methods be used for exhaustive detection and 214 
differentiation of gut parasites, problems arise when DNA is annotated to the species—or even 215 
genus—level. Some parasites exhibit remarkable genetic diversity, and while genomic data for e.g. 216 
Blastocystis and Dientamoeba is appearing in publicly available databases [75-80], a couple of 217 
nuclear ribosomal rDNA sequences is the only available genome data for other intestinal parasites 218 
such as Iodamoeba and Endolimax [81-83] and also for even more common parasites such as 219 
Entamoeba coli [84]. Therefore, in order to optimize mapping of sequenced parasite DNA, genomic 220 
data on such parasites should be made available. Moreover, several common intestinal parasites 221 
exhibit remarkably extensive genetic diversity, and the research looking into associations between 222 
various genotypes/subtypes/strains and eubiosis/dysbiosis remains limited. Finally, few studies have 223 
taken into account colonization by fungi such as yeasts (Candida, Saccharomyces, etc.), and there is 224 
hardly any qualitative or quantitative information on inter-fungal relationships and relationships 225 
between fungi and other microbial inhabitants of the gut.  226 
 227 
Perspectives   228 
Probiotics have been used to prevent but also treat protozoal infections, exemplified in a recent 229 
review by Vitetta et al. [38], and so future investigations may benefit from looking deeper into how 230 
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administration of probiotics might interfere with parasite colonization. In this context, it would also 231 
appear relevant to mention faecal microbiota transplantation (FMT), which has gained a lot in 232 
popularity over the recent years, especially for the treatment of recurrent Clostridium difficile 233 
infection [85, 86]. Future use of FMT might include alleviation and/or treatment of other diseases, 234 
including IBD, type 2 diabetes, metabolic disease, and maybe even neuropsychiatric diseases [87, 235 
88]. The presence and effect of e.g. Blastocystis and Dientamoeba in donor stool is largely 236 
overlooked. There seems to be lack of consensus as to which organisms should rule out donors; 237 
examples of Blastocystis and Dientamoeba colonization being obstacles to accepting FMT donors 238 
exist [89, 90]; meanwhile, other recommendations do not include these parasites in the panel of 239 
pathogens disqualifying donors [91]. Nevertheless, if i) high microbiota diversity is linked to 240 
parasite colonization, ii) high microbiota diversity is an attractive asset of FMT donor stool, and iii), 241 
parasite colonization is linked to gut health-promoting bacterial communities, future investigations 242 
should look into the effect of co-administering common intestinal parasites to patients with 243 
conditions for which FMT is used, and also into whether in fact these parasites can be transplanted 244 
from a donor to a recipient using FMT. 245 
 246 
Concluding Remarks 247 
While we still know little about the potential pathogenicity of common luminal intestinal parasites, 248 
epidemiological data strongly suggest that at least some of these parasites are linked to 249 
gastrointestinal health rather than disease. Based on profiling of gut bacterial communities, we are 250 
learning to predict whether or not an individual is colonized with intestinal parasites. This article 251 
has provided some hypotheses and ideas for studies that could help us detail and strengthen our 252 
knowledge regarding associations between parasites and gut microbiota, with a view to exploring 253 
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the importance of these parasites in public health and clinical settings and their potential as gut 254 




Figure legend 259 
Figure 1. Dynamic interplay between gut flora and human colonocytes. In a healthy gut, 260 
fermentation by obligate anaerobic bacteria and Blastocystis results in increased short chain fatty 261 
acid production. Butyrate is the preferred metabolic substrate of colonocytes and used in 262 
mitochondrial β-oxidation producing ATP, resulting in a decrease of available oxygen. In addition, 263 
butyrate is sensed by the nuclear PPAKγ receptor, which suppresses iNOS and thereby nitrate in the 264 
intestinal lumen. Butyrate enhances mitochondrial oxidative phosphorylation. Overall, this results 265 
in a hypoxic intestinal lumen, which supports a microbiota dominated by health-enhancing 266 
microbes and which favours continued colonisation by Blastocystis. In dysbiosis, the increase in 267 
facultative anaerobes such as Enterobacteriaceae results in a decrease of available butyrate. As a 268 
result, colonocyte metabolism shifts away from β-oxidation and oxidative phosphorylation to 269 
increased glycolysis and therefore does not reduce the oxygen concentration. The nuclear PPAKγ 270 
receptor no longer suppresses iNOS, resulting ultimately in increased nitrate in the gut that can be 271 







Probiotics: Live micro-organisms, which, when administered in adequate amounts, confer a health 277 
benefit on the host. 278 
Dysbiosis/Eubiosis: The human gut is colonized primarily be species belonging to the following 279 
phyla: Firmicutes, Bacteroidetes, Proteobacteria, Verrucomicrobia, Actinobacteria and Fusobacteria 280 
[92, 93]. To give a distinct definition of dysbiosis and eubiosis is not straightforward, but has 281 
nevertheless been attempted: A gut microbiota in a eubiotic state is characterized by a 282 
preponderance of potentially beneficial species, belonging mainly to the two bacterial phylum 283 
Firmicutes and Bacteroides, while potentially pathogenic species, such as those belonging to the 284 
phylum Proteobacteria (Enterobacteriaceae) are present, but in a very low percentage. In the case of 285 
dysbiosis, “good bacteria” no longer control the “bad bacteria”, which take over [92]. While the use 286 
of this definition might be pragmatic in some situations, it should be noted that a clear dichotomy 287 
between beneficial and pathogenic species is unlikely to exist. Secondly, this definition considers 288 
beneficial taxa to be mostly Firmicutes and Bacteroides, while pathogenic species would be mostly 289 
Proteobacteria; obviously, the situation is more complex. For instance, changes in the 290 
Firmicutes/Bacteroides ratio, as for example observed in obese individuals [94], also appears to be 291 
associated with dysbiosis. Less concrete and more holistic definitions are given by Miniello et al., 292 
“Beyond the microbial richness and diversity, a ‘eubiotic’ gut microbiota is characterized by the 293 
presence of the microbes that enhance metabolism, resilience to inflammation, resistance to 294 
autoimmunity. Dysbiosis is considered as an alteration in microbiota community structure and/or 295 
function, capable of causing/driving a detrimental distortion of microbe-host homeostasis.” [95] 296 
16S analysis: Also referred to by some  as “metagenomic” analysis. In fact, 16S analysis usually 297 
refers to the procedure where genomic DNA from a given sample is subject to broad-specificity 298 
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amplification of bacterial small subunit ribosomal DNA, sequenced by a next-generation 299 
sequencing method, and annotated to a taxonomic level by the use of online databases. 300 
Enterotype: In a study by Arumugam et al. [48], application of multidimensional cluster analysis 301 
and principal component analysis to fecal metagenomes revealed three distinct clusters, the so-302 
called enterotypes, each of which is characterized by a dominance in abundance of one of three 303 
bacterial genera: Bacteroides (enterotype 1), Prevotella (enterotype 2), and Ruminococcus 304 
(enterotype 3). 305 
GUt Low-Density Array (GULDA): is a validated, high-throughput real-time quantitative PCR-306 
based analysis platform developed for simultaneous analysis of differences in abundance of 31 307 
different microbial 16S gene targets in faecal samples. 308 
‘Old Friends’ hypothesis: Development of the immune system requires input from at least three 309 
sources collectively referred to as the ‘old friends’: (i) the commensal microbiotas transmitted by 310 
mothers and other family members; (ii) organisms from the natural environment that modulate and 311 
diversify the commensal microbiotas; and (iii) the ‘old’ infections that could persist in small 312 
isolated hunter-gatherer groups as relatively harmless subclinical infections or carrier states. These 313 
categories of organisms have to be tolerated and hence play a role in the development and 314 
regulation of the immune system [96]. 315 
PICRUSt analysis: Phylogenetic Investigation of Communities by Reconstruction of Unobserved 316 
States (PICRUSt) is a bioinformatics software package designed to predict metagenome functional 317 
content from marker gene (e.g., 16S rRNA) surveys and full genomes 318 
(http://picrust.github.io/picrust/). 319 
Faecal microbiota transplantation (FMT): is a procedure in which faecal matter, or stool, is 320 
collected from a donor, mixed with a saline or other solution, strained, and infused in a patient 321 
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(recipient) by, for instance, colonoscopy or an orogastric tube with a view to restoring a healthy 322 
intestinal microbiota. 323 
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Table 1. Examples of studies on associations between intestinal parasites (protists only) and gut microbial communities. 525 
Method Parasite Association(s) observed Reference 
Metagenomics Blastocystis Inverse association between body mass index and Blastocystis and strong co-
occurrence with archaeal organisms (Methanobrevibacter smithii) and several 
bacterial species. Negative association between Blastocystis and levels of 
Bacteroides. 
[23] 
Real-time PCR Blastocystis Linked to eubiosis; significantly higher Faecalibacterium prausnitzii-Escherichia 
coli ratio in Blastocystis-positive than in Giardia-positive individuals. 
[47] 
Real-time PCR Entamoeba Linked to eubiosis; significantly higher Faecalibacterium prausnitzii-Escherichia 
coli ratio in Entamoeba-positive than in Giardia-positive individuals. 
[47] 
Real-time PCR Giardia Linked to dysbiosis; significantly lower Faecalibacterium prausnitzii-Escherichia 
coli ratio in Giardia-positive than in Entamoeba- and Blastocystis-positive 
individuals. 
[47] 
Metagenomics Blastocystis Blastocystis found in individuals with Prevotella and Ruminococcus enterotypes and 
not in those with Bacteroides enterotype; Blastocystis colonisation linked to higher 
bacterial richness. 
[35] 
Real-time PCR Blastocystis Low relative abundances of Bacteroides and clostridial cluster XIVa and high levels 




Entamoeba Relative abundance of the phyla Cyanobacteria, Elusimicrobia, Euryarchaeota, 
Firmicutes, Spirochaetes, Tenericutes all higher in Entamoeba-positive individuals. 





Blastocystis Higher bacterial diversity in the faecal microbiota of Blastocystis-positive patients, a 
higher abundance of Clostridia, and a lower abundance of Enterobacteriaceae. 
[41] 
Real-time PCR Blastocystis Levels of “gut protective” Faecalibacterium prausnitzii were decreased in 
Blastocystis-colonised males and levels of Bifidobacterium sp. were decreased in 




Blastocystis Blastocystis-positive individuals had increased bacterial diversity, but no significant 




Metagenomics Blastocystis The relative abundance of bacteria belonging to Bacteroides was lower in 
Blastocystis carriers compared with non-carriers, and Blastocystis carriage was also 
associated with significantly higher bacterial richness. 
[97] 
 526 
OUTSTANDING QUESTIONS BOX 
1. Can current evidence of links between intestinal parasites and microbiota diversity from 
cross-sectional studies be confirmed and further investigated by data from longitudinal 
studies? 
2. What is the relationship between common parasites and fungi colonizing the intestinal tract 
in terms of abundance and diversity? Similarly, are intestinal eukaryotic microbial 
communities found in people consuming non-western diets a potential avenue to exploring 
how to prevent western diseases? 
3. Can hypotheses be generated on links between parasites and certain bacterial taxa, and can 
in vivo and in vitro models be developed and included in prospective studies to provide 
supportive evidence of such links? 
4. Are intestinal parasites merely indicators of particular gut microbiota profiles or are they 
modulators, actively impacting the structure and function of gut microbiota?  
5. The answer to 4) will also answer the question as to whether intestinal protists are 
interesting mainly from a public health view point or also from a clinical/therapeutic view 
point. 
6. Are bacteria driving not only the ability of parasites to establish but also their virulence? 
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